
Misook Yu
Supervisory Patent Examiner (ID: 1022, Phone: (571)272-0839 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1641 |
| Total Applications | 859 |
| Issued Applications | 261 |
| Pending Applications | 201 |
| Abandoned Applications | 403 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6710498
[patent_doc_number] => 20030170247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Methods for detection and treatment of neural cancers'
[patent_app_type] => new
[patent_app_number] => 10/382945
[patent_app_country] => US
[patent_app_date] => 2003-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18872
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170247.pdf
[firstpage_image] =>[orig_patent_app_number] => 10382945
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/382945 | Methods for detection and treatment of neural cancers | Mar 5, 2003 | Issued |
Array
(
[id] => 698497
[patent_doc_number] => 07067280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => 'Human cartilage glycoprotein'
[patent_app_type] => utility
[patent_app_number] => 10/373802
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6588
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067280.pdf
[firstpage_image] =>[orig_patent_app_number] => 10373802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/373802 | Human cartilage glycoprotein | Feb 26, 2003 | Issued |
Array
(
[id] => 7398932
[patent_doc_number] => 20040023260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => '29 human secreted proteins'
[patent_app_type] => new
[patent_app_number] => 10/373809
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56096
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023260.pdf
[firstpage_image] =>[orig_patent_app_number] => 10373809
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/373809 | 29 human secreted proteins | Feb 26, 2003 | Abandoned |
Array
(
[id] => 6701522
[patent_doc_number] => 20030224402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Progression suppressed gene 13 (PSGen 13) and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/373556
[patent_app_country] => US
[patent_app_date] => 2003-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11843
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224402.pdf
[firstpage_image] =>[orig_patent_app_number] => 10373556
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/373556 | Progression suppressed gene 13 (PSGen 13) and uses thereof | Feb 23, 2003 | Abandoned |
Array
(
[id] => 6678160
[patent_doc_number] => 20030228300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Sterile immunogenic non-tumorigenic tumor cell compositions and methods'
[patent_app_type] => new
[patent_app_number] => 10/370081
[patent_app_country] => US
[patent_app_date] => 2003-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12457
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228300.pdf
[firstpage_image] =>[orig_patent_app_number] => 10370081
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/370081 | Sterile immunogenic non-tumorigenic tumor cell compositions and methods | Feb 20, 2003 | Issued |
Array
(
[id] => 5743182
[patent_doc_number] => 20060088907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Novel 13237, 18480, 2245, 16228, 7677, 26320, 46619, 33166, 16836, 46867, 21617, 55562, 39228, 62088, 46745, 23155, 21657, 42755, 32229, 22325, 46863 and 32252 molecules and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/370959
[patent_app_country] => US
[patent_app_date] => 2003-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 149628
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088907.pdf
[firstpage_image] =>[orig_patent_app_number] => 10370959
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/370959 | Novel 13237, 18480, 2245, 16228, 7677, 26320, 46619, 33166, 16836, 46867, 21617, 55562, 39228, 62088, 46745, 23155, 21657, 42755, 32229, 22325, 46863 and 32252 molecules and uses therefor | Feb 19, 2003 | Abandoned |
Array
(
[id] => 6740175
[patent_doc_number] => 20030157544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators'
[patent_app_type] => new
[patent_app_number] => 10/366487
[patent_app_country] => US
[patent_app_date] => 2003-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25753
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157544.pdf
[firstpage_image] =>[orig_patent_app_number] => 10366487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/366487 | Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators | Feb 11, 2003 | Abandoned |
Array
(
[id] => 6846787
[patent_doc_number] => 20030165954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Cancer profiles'
[patent_app_type] => new
[patent_app_number] => 10/339533
[patent_app_country] => US
[patent_app_date] => 2003-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29198
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10339533
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/339533 | Cancer profiles | Jan 8, 2003 | Abandoned |
Array
(
[id] => 6797469
[patent_doc_number] => 20030176343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Diagnostics and therapeutic uses of topors'
[patent_app_type] => new
[patent_app_number] => 10/339924
[patent_app_country] => US
[patent_app_date] => 2003-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 8139
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176343.pdf
[firstpage_image] =>[orig_patent_app_number] => 10339924
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/339924 | Diagnostics and therapeutic uses of topors | Jan 8, 2003 | Abandoned |
Array
(
[id] => 563996
[patent_doc_number] => 07465553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-16
[patent_title] => 'Psoriasin expression by breast epithelial cells'
[patent_app_type] => utility
[patent_app_number] => 10/331200
[patent_app_country] => US
[patent_app_date] => 2002-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 11242
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/465/07465553.pdf
[firstpage_image] =>[orig_patent_app_number] => 10331200
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/331200 | Psoriasin expression by breast epithelial cells | Dec 29, 2002 | Issued |
Array
(
[id] => 7374709
[patent_doc_number] => 20040093621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Antibody composition which specifically binds to CD20'
[patent_app_type] => new
[patent_app_number] => 10/327663
[patent_app_country] => US
[patent_app_date] => 2002-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 48568
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20040093621.pdf
[firstpage_image] =>[orig_patent_app_number] => 10327663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/327663 | Antibody composition which specifically binds to CD20 | Dec 23, 2002 | Abandoned |
Array
(
[id] => 6740163
[patent_doc_number] => 20030157532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Method for identifying compounds altering higher-order chromatin-dependent chromosome stability'
[patent_app_type] => new
[patent_app_number] => 10/323968
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 20675
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10323968
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/323968 | Method for identifying compounds altering higher-order chromatin-dependent chromosome stability | Dec 19, 2002 | Abandoned |
Array
(
[id] => 7429706
[patent_doc_number] => 20040001842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors'
[patent_app_type] => new
[patent_app_number] => 10/323692
[patent_app_country] => US
[patent_app_date] => 2002-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16666
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20040001842.pdf
[firstpage_image] =>[orig_patent_app_number] => 10323692
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/323692 | Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors | Dec 18, 2002 | Abandoned |
Array
(
[id] => 6769505
[patent_doc_number] => 20030215445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Methods and compositions for inhibiting the growth of hematopoietic malignant cells'
[patent_app_type] => new
[patent_app_number] => 10/321587
[patent_app_country] => US
[patent_app_date] => 2002-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 18018
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215445.pdf
[firstpage_image] =>[orig_patent_app_number] => 10321587
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/321587 | Methods and compositions for inhibiting the growth of hematopoietic malignant cells | Dec 17, 2002 | Abandoned |
Array
(
[id] => 7469146
[patent_doc_number] => 20040102407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer'
[patent_app_type] => new
[patent_app_number] => 10/313972
[patent_app_country] => US
[patent_app_date] => 2002-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 118338
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102407.pdf
[firstpage_image] =>[orig_patent_app_number] => 10313972
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/313972 | Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer | Dec 5, 2002 | Issued |
Array
(
[id] => 6778158
[patent_doc_number] => 20030049239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Therapeutic compositions and methods for treating tumors'
[patent_app_type] => new
[patent_app_number] => 10/301328
[patent_app_country] => US
[patent_app_date] => 2002-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7306
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10301328
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/301328 | Therapeutic compositions and methods for treating tumors | Nov 20, 2002 | Abandoned |
Array
(
[id] => 243180
[patent_doc_number] => 07588914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Bacterial Bcl-2 domain-containing polypeptides, encoding nucleic acid molecules, and related methods'
[patent_app_type] => utility
[patent_app_number] => 10/294445
[patent_app_country] => US
[patent_app_date] => 2002-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14960
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/588/07588914.pdf
[firstpage_image] =>[orig_patent_app_number] => 10294445
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/294445 | Bacterial Bcl-2 domain-containing polypeptides, encoding nucleic acid molecules, and related methods | Nov 12, 2002 | Issued |
Array
(
[id] => 281821
[patent_doc_number] => 07553821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-30
[patent_title] => 'Methods for selectively modulating survivin apoptosis pathways'
[patent_app_type] => utility
[patent_app_number] => 10/291607
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 36
[patent_no_of_words] => 19948
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/553/07553821.pdf
[firstpage_image] =>[orig_patent_app_number] => 10291607
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/291607 | Methods for selectively modulating survivin apoptosis pathways | Nov 11, 2002 | Issued |
Array
(
[id] => 232913
[patent_doc_number] => 07598340
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-06
[patent_title] => 'Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses'
[patent_app_type] => utility
[patent_app_number] => 10/292541
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10777
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/598/07598340.pdf
[firstpage_image] =>[orig_patent_app_number] => 10292541
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/292541 | Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses | Nov 11, 2002 | Issued |
Array
(
[id] => 6730185
[patent_doc_number] => 20030186375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Nuclear myosin I beta with a 16 amino acid N-terminal extension'
[patent_app_type] => new
[patent_app_number] => 10/287216
[patent_app_country] => US
[patent_app_date] => 2002-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7536
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186375.pdf
[firstpage_image] =>[orig_patent_app_number] => 10287216
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/287216 | Nuclear myosin I beta with a 16 amino acid N-terminal extension | Nov 3, 2002 | Abandoned |